In a filing, Confluent Inc revealed its Chief Accounting Officer Phan Kong unloaded Company’s shares for reported $0.14 million on Dec 22 ’25. In the deal valued at $29.96 per share,4,545 shares were sold. As a result of this transaction, Phan Kong now holds 220,505 shares worth roughly $6.71 million.
Then, Mac Ban Ryan Norris sold 3,053 shares, generating $91,468 in total proceeds. Upon selling the shares at $29.96, the Chief Revenue Officer now owns 332,679 shares.
Before that, Mac Ban Ryan Norris sold 1,218 shares. Confluent Inc shares valued at $36,491 were divested by the Chief Revenue Officer at a price of $29.96 per share. As a result of the transaction, Mac Ban Ryan Norris now holds 335,732 shares, worth roughly $10.21 million.
Citizens JMP downgraded its Confluent Inc [CFLT] rating to a Mkt perform from a a Mkt outperform in a research note published recently. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in early October with a ‘”an Overweight”‘ rating. TD Cowen also remained covering CFLT and has decreased its forecast on July 31, 2025 with a “Hold” recommendation from previously “Buy” rating. Stifel revised its rating on July 31, 2025. It rated CFLT as “a Hold” which previously was an “a Buy”.
Price Performance Review of CFLT
On Tuesday, Confluent Inc [NASDAQ:CFLT] saw its stock fall -0.03% to $30.42. Over the last five days, the stock has gained 0.80%. Confluent Inc shares have risen nearly 10.06% since the year began. Nevertheless, the stocks have risen 0.60% over the past one year.
How much short interest is there in Confluent Inc?
A steep rise in short interest was recorded in Confluent Inc stocks on 2025-12-31, dropping by -0.89 million shares to a total of 18.16 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 19.05 million shares. There was a decline of -4.88%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on July 18, 2025 when Stephens began covering the stock and recommended ‘”an Overweight”‘ rating along with a $31 price target.
